Ophthalmology

Top Story

OSNAPAO: Should we use prophylaxis topical antibiotics after intravitreal injections?

July 30, 2015

Intravitreal delivery of medications by injection through the pars plana has become a routine ophthalmic procedure since anti-VEGF medicines became commercialized. Due to the huge number of intravitreal injections every year — and this number is assumed to be increasing continuously — the complications from intravitreal injection have received more attention, especially the serious adverse complications. One of the most feared complications is endophthalmitis. According to recent studies, the incidence of endophthalmitis after intravitreal injection of anti-VEGFs has been reported to be in the range of 0.02% to 0.085%. A current debate is whether prophylactic antibiotics should be used or not.

In the Journals

Avastin before glaucoma valve implantation may lead to less hyphema, fewer medications postop

July 29, 2015
A preoperative intravitreal bevacizumab injection before Ahmed glaucoma valve implantation may decrease postoperative hyphema and lower the number of glaucoma…
BLOG: Bridging the reimbursement gap, part 7 BlogVideo

BLOG: Bridging the reimbursement gap, part 7

July 29, 2015
In this installment of the series, Cynthia A. Matossian, MD, discusses retina gene testing, a genetic test that is able to predict the patient's lifetime risk of…
In the JournalsPerspective

Health care spending expected to increase over decade, but at historically low rate

July 29, 2015
Due to expanded health insurance coverage from the ACA, as well as the aging population and economic growth, health care spending is projected to increase at a rate of…
Business News

Phase 3 clinical trial strategy developed for Inotek’s trabodenoson

July 29, 2015
Inotek Pharmaceuticals intends to begin a phase 3 clinical trial of its leading glaucoma drug candidate, trabodenoson, in the fourth quarter of 2015, the company…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Real-world Use of Anti-VEGF Therapy

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Meeting News Coverage Video
VIDEO: Defining and treating astigmatism

VIDEO: Defining and treating astigmatism

July 26, 2015
At the Kiawah Eye 2015 meeting, John A. Hovanesian, MD, FACS, discusses how treating astigmatism in patients will…
More »
morganatic-roan
morganatic-roan